PubMed=12780797; DOI=10.1046/j.1365-2141.2003.04359.x
Zhang Y., Nagata H., Ikeuchi T., Mukai H., Oyoshi M.K., Demachi A., Morio T., Wakiguchi H., Kimura N., Shimizu N., Yamamoto K.
Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Br. J. Haematol. 121:805-814(2003)

PubMed=21052088; DOI=10.1038/leu.2010.255
Iqbal J., Weisenburger D.D., Chowdhury A., Tsai M.-Y., Srivastava G., Greiner T.C., Kucuk C., Deffenbacher K.E., Vose J.M., Smith L., Au W.Y., Nakamura S., Seto M., Delabie J., Berger F., Loong F., Ko Y.-H., Sng I., Liu X., Loughran T.P. Jr., Armitage J.O., Chan W.-C.
International Peripheral T-cell Lymphoma Project
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Leukemia 25:348-358(2011)

PubMed=22102884; DOI=10.1371/journal.pone.0027271; PMCID=PMC3213120
Ramakrishnan R., Donahue H., Garcia D., Tan J., Shimizu N., Rice A.P., Ling P.D.
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
PLoS ONE 6:e27271.1-e27271.12(2011)